PortfoliosLab logoPortfoliosLab logo
RIVN vs. MRNA
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

RIVN vs. MRNA - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Rivian Automotive, Inc. (RIVN) and Moderna, Inc. (MRNA). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, RIVN achieves a -14.97% return, which is significantly lower than MRNA's 69.24% return.


RIVN

1D
7.85%
1M
21.54%
YTD
-14.97%
6M
-9.01%
1Y
24.89%
3Y*
3.20%
5Y*
10Y*

MRNA

1D
0.54%
1M
1.77%
YTD
69.24%
6M
69.42%
1Y
87.14%
3Y*
-26.94%
5Y*
-25.59%
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

RIVN vs. MRNA - Yearly Performance Comparison


2026 (YTD)20252024202320222021
RIVN
Rivian Automotive, Inc.
-14.97%48.20%-43.31%27.29%-82.23%-2.87%
MRNA
Moderna, Inc.
69.24%-29.08%-58.19%-44.63%-29.28%7.23%

Correlation

The correlation between RIVN and MRNA is 0.26, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.26

Correlation (3Y)
Calculated over the trailing 3-year period

0.31

Correlation (All Time)
Calculated using the full available price history since Nov 10, 2021

0.34

Fundamentals

Market Cap

RIVN:

$20.93B

MRNA:

$19.71B

EPS

RIVN:

-$2.90

MRNA:

-$8.16

PS Ratio

RIVN:

3.68

MRNA:

8.78

PB Ratio

RIVN:

4.73

MRNA:

2.66

Total Revenue (TTM)

RIVN:

$5.53B

MRNA:

$2.23B

Gross Profit (TTM)

RIVN:

$57.00M

MRNA:

-$309.00M

EBITDA (TTM)

RIVN:

-$3.18B

MRNA:

-$3.02B

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

RIVN vs. MRNA — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

RIVN
RIVN Risk / Return Rank: 5555
Overall Rank
RIVN Sharpe Ratio Rank: 5454
Sharpe Ratio Rank
RIVN Sortino Ratio Rank: 5858
Sortino Ratio Rank
RIVN Omega Ratio Rank: 5454
Omega Ratio Rank
RIVN Calmar Ratio Rank: 5454
Calmar Ratio Rank
RIVN Martin Ratio Rank: 5454
Martin Ratio Rank

MRNA
MRNA Risk / Return Rank: 7878
Overall Rank
MRNA Sharpe Ratio Rank: 8080
Sharpe Ratio Rank
MRNA Sortino Ratio Rank: 7979
Sortino Ratio Rank
MRNA Omega Ratio Rank: 7575
Omega Ratio Rank
MRNA Calmar Ratio Rank: 7979
Calmar Ratio Rank
MRNA Martin Ratio Rank: 7676
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

RIVN vs. MRNA - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Rivian Automotive, Inc. (RIVN) and Moderna, Inc. (MRNA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


RIVNMRNADifference
Sharpe ratioReturn per unit of total volatility

-0.97

Sortino ratioReturn per unit of downside risk

-1.07

Omega ratioGain probability vs. loss probability

1.12

1.24

-0.12

Calmar ratioReturn relative to maximum drawdown

0.48

2.34

-1.85

Martin ratioReturn relative to average drawdown

0.95

4.59

-3.64

RIVN vs. MRNA - Sharpe Ratio Comparison

The current RIVN Sharpe Ratio is 0.31, which is lower than the MRNA Sharpe Ratio of 1.28. The chart below compares the historical Sharpe Ratios of RIVN and MRNA, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

RIVN vs. MRNA - Drawdown Comparison

The maximum RIVN drawdown since its inception was -95.12%, roughly equal to the maximum MRNA drawdown of -95.38%. Use the drawdown chart below to compare losses from any high point for RIVN and MRNA.


Loading charts...

Drawdown Indicators


RIVNMRNADifference

Max Drawdown

Largest peak-to-trough decline

-95.12%

-95.38%

+0.26%

Max Drawdown (1Y)

Largest decline over 1 year

-42.54%

-35.51%

-7.03%

Max Drawdown (3Y)

Largest decline over 3 years

-69.61%

-86.58%

+16.97%

Max Drawdown (5Y)

Largest decline over 5 years

-95.38%

Current Drawdown

Current decline from peak

-90.26%

-89.70%

-0.56%

Average Drawdown

Average peak-to-trough decline

-86.33%

-57.06%

-29.27%

Ulcer Index

Depth and duration of drawdowns from previous peaks

21.62%

18.06%

+3.56%

Volatility

RIVN vs. MRNA - Volatility Comparison

Rivian Automotive, Inc. (RIVN) has a higher volatility of 22.66% compared to Moderna, Inc. (MRNA) at 17.56%. This indicates that RIVN's price experiences larger fluctuations and is considered to be riskier than MRNA based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


RIVNMRNADifference

Volatility (1M)

Calculated over the trailing 1-month period

22.66%

17.56%

+5.10%

Volatility (6M)

Calculated over the trailing 6-month period

49.82%

48.82%

+1.00%

Volatility (1Y)

Calculated over the trailing 1-year period

65.46%

64.75%

+0.71%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

77.55%

66.49%

+11.06%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

77.55%

72.15%

+5.40%

Dividends

RIVN vs. MRNA - Dividend Comparison

Neither RIVN nor MRNA has paid dividends to shareholders.


Tickers have no history of dividend payments

Financials

RIVN vs. MRNA - Financials Comparison

This section allows you to compare key financial metrics between Rivian Automotive, Inc. and Moderna, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.001.00B2.00B3.00B4.00B5.00B6.00B7.00B20222023202420252026
1.38B
389.00M
(RIVN) Total Revenue
(MRNA) Total Revenue
Values in USD except per share items

Frequently Asked Questions


RIVN and MRNA have a correlation of 0.26, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

RIVN has higher volatility (22.66%) compared to MRNA (17.56%). In terms of maximum drawdown, RIVN dropped -95.12% vs MRNA's -95.38%.

MRNA currently has the higher Sharpe Ratio (1.28 vs 0.31), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for RIVN and MRNA

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer